This Week in Clinical Cancer Research | GenomeWeb

In Clinical Cancer Research this week, researchers in Scandinavia and the US report that their molecular profiling of primary melanoma revealed low-grade and high-grade forms of the disease. The team analyzed RNA expression, oncogenic mutations, histomorphometry, and survival data from 223 archival primary melanomas, and found that the previously established four-class structure of primary melanoma converged into two larger prognostic and phenotypic groups.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.